Abstract
Background:
The primary objective of this study was to measure influenza vaccination coverage rates in the general population, including children, and in high-risk groups of five European countries during the season 2007/2008. An additional aim was to analyze coverage trends over seven consecutive seasons and to gain an understanding of the primary drivers and barriers to immunization.
Methods:
Community-based telephone and mail surveys have been conducted in the UK, Germany, Italy, France, and Spain, yearly, since 2001/2002. Approximately 2,000 individuals per country and season were interviewed who were considered to be representative of the adult population aged 14 years and older. Data on the vaccination status of children were obtained by proxy interviews. The questionnaire used was essentially the same for all seven seasons. Five target groups were identified for the study: (1) persons aged ≥ 65 years; (2) elderly suffering from a chronic illness; (3) patients suffering from a chronic illness; (4) persons working in the health care sector; (5) children.
Results:
In the season 2007/2008, vaccination coverage rates in the general population remained stable in Germany. Compared to the coverage rates of the previous season, increases of 3.7%, 2.0%, and 1.8% were observed for the UK, Spain, and France, respectively, while a decrease of –1.5% was observed for Italy. Across all five countries, vaccination rates in the predefined target groups decreased to some extent (elderly) or increased slightly (chronically ill and health care workers). Vaccination rates among children varied strongly between countries and ranged from 6.1% in UK to 19.3% in Germany. The most powerful motivation for getting vaccinated in all countries was advice from a family doctor (58.6%) and the perception of influenza as a serious illness (51.9%). The major reasons why individuals did not become vaccinated were (1) the feeling of not being likely to catch influenza (39.5%) and (2) never having considered the option of being vaccinated (35.8%).
Conclusions:
The change in general influenza vaccination coverage in the 2007/2008 season compared to the previous season was small, but decreases were seen in some target groups. The underlying motivations for and against vaccination did not substantially change. An effort to activate those driving forces that would encourage vaccination as well as dealing with barriers that tend to prevent it may help enhance coverage rates in Europe in the future.
Similar content being viewed by others
References
European Centre for Disease Prevention and Control (ECDC): Surveillance of communicable diseases in the European Union - a long-term strategy: 2008–2013. ECDC: Stockholm 2008.
Influenza, Fact sheet No 211. Revised March 2003 [cited 15 July 2008]. Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.
Centers for Disease Control (CDC): Prevention and control of influenza: recommendations of the advisory committee on immunization practices (ACIP). Atlanta: CDC 2006.
Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA: The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661–1665.
Edwards KM, Dupont WD, Westrich MK, Plummer WD Jr, Palmer PS, Wright PF: A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis 1994; 169: 68–76.
Zangwill KM, Belshe RB: Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the newera of routine vaccination. Pediatr Infect Dis J 2004; 23: 189–197.
Nichol KL, Goodman M: The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years. Pharmacoeconomics 1999; 16: 63–71.
Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E: Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357: 1373–1381.
Scuffham PA, West PA: Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine 2002; 20: 2562–2578.
Barnett ED: Influenza immunization for children. N Engl J Med 1998; 338: 1459–1461.
Ghendon YZ, Kaira AN, Elshina GA: The effect of mass influenza immunization in children on the morbidity of the unvaccinated elderly. Epidemiol Infect 2006; 134: 71–78.
King JC Jr, Stoddard JJ, Gaglani MJ, Moore KA, Magder L, McClure E, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006; 355: 2523–2532.
European Parliament: European Parliament resolution on the strategy against an influenza pandemic. European Parliament: Strasbourg 2005.
Decision adopted jointly by the European Parliament and the Council - Decision No 1350/2007/EC of the European Parliament and of the Council of 23 October 2007 - Establishing a second programme of Community action in the field of health (2008-2013) (Text with EEA relevance). Off J Eur Union. 2007 Nov 20:L 301/3–/13.
Donaldson L: The influenza immunisation programme 2008/09. Department of Health: London 2008.
Ständige Impfkommission (STIKO) am Robert-Koch-Institut (Chairman Hofmann F). Empfehlungen der Ständigen Impf-kommission (STIKO) am Robert-Koch-Institut/Stand: Epidemiol Bull 2008 (30): 235–254.
Direction générale de la santé: Guide des vaccinations. In: Vaccinations. Paris 2006.
Ministero della Salute: Direzione generale della prevenzione sanitaria. Prevenzione e controllo dell’influenza: raccomandazioni per la stagione 2007–2008. Circolareno 1 del 2 agosto 2007 (DGPREV.V/20973/P/I.4.c.a.9). Ministero della Salute: Madrid 2007.
Ministerio de Sanidad y Consumo: Prevención de la Gripe. Ministerio de Sanidad y Consumo: Madrid 2009.
Ramet J, Weil-Olivier C, Sedlak W: Influenza vaccination: the paediatric perspective. Vaccine 2007; 25: 780–787.
Muller D, Nguyen-Van-Tam JS, Szucs TD: Influenza vaccination coverage rates in the UK: a comparison of two monitoring methods during the 2002–2003 and 2003—2004 seasons. Public Health 2006; 120: 1074–1080.
Szucs TD, Muller D: Influenza vaccination coverage rates in five European countries-a population-based cross-sectional analysis of two consecutive influenza seasons. Vaccine 2005; 23: 5055–5063.
ICC/ESOMAR International Code of Marketing and Social Research Practice: Esomar World research codes and guidelines: ICC/ESOMAR International Code of Marketing and Social Research Practice, 2005.
Holm MV, Blank PR, Szucs TD: Developments in influenza vaccination coverage in England, Scotland, Wales covering five consecutive seasons from 2001 to 2006. Vaccine 2007; 25: 7931–7938.
Holm MV, Blank PR, Szucs TD: Trends in influenza vaccination coverage rates in Germany over five seasons from 2001 to 2006. BMC Infect Dis 2007; 7: 144.
Blank PR, Schwenkglenks M, Szucs TD: Influenza vaccination coverage rates in five European countries during season 2006/07 and trends over six consecutive seasons. BMC public health 2008; 8: 272.
Marti F, Steffen R, Mutsch M: Influenza vaccine: a travelers’ vaccine? Expert Rev Vaccines 2008; 7: 679–687.
VENICE (Vaccine European New Integrated Collaboration Effort): Report on the Vaccination Coverage Assessment In Europe, 2007.
Lavrakas P: Telephone survey methods: sampling, selection, and supervision (2nd edn). Sage Publications, Beverly Hills 1993.
MacDonald R, Baken L, Nelson A, Nichol KL: Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients. Am J Prev Med 1999; 16: 173–177.
Martin LM, Leff M, Calonge N, Garrett C, Nelson DE: Validation of self-reported chronic conditions and health services in a managed care population. Am J Prev Med 2000; 18: 215–218.
Kempf AM, Remington PL: New challenges for telephone survey research in the twenty-first century. Annu Rev Public Health 2007; 28: 113–126.
Kroneman M, van Essen GA, John Paget W: Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine 2006; 24: 622–628.
Johnson DR, Nichol KL, Lipczynski K: Barriers to adult immunization. Am J Med 2008; 121 (7 Suppl 2): S28–S35.
Jacobson VJ, Szilagyi P: Patient reminder and patient recall systems to improve immunization rates. Cochrane Database Syst Rev 2005; (3): CD003941.
Leitmeyer K, Buchholz U, Kramer M, Schenkel K, Stahlhut H, Kollstadt M, et al. Influenza vaccination in German health care workers: effects and findings after two rounds of a nationwide awareness campaign. Vaccine 2006; 24: 7003–7008.
Maltezou HC, Maragos A, Raftopoulos V, Karageorgou K, Halharapi T, Remoudaki H, et al. Strategies to increase influenza vaccine uptake among health care workers in Greece. Scand J Infect Dis 2008; 40: 266–268.
Begum F, Pebody R: Influenza vaccination uptake in the 65 years and above and under 65 year olds at risk in England, 2007–2008. Influenza Immunisation Uptake Monitoring Programme. Department of Health: London 2008.
Department of Health: The influenza immunisation programme 2008/09. Department of Health: London 2008.
Blank PR, Szucs TD: Authors’ reply: Influenza vaccination coverage in the United Kingdom. Eurosurveillance 2008; 13(51).
Principi N, Esposito S: Are we ready for universal influenza vaccination in paediatrics? Lancet Infect Dis 2004; 4: 75–83.
Hurwitz ES, Haber M, Chang A, Shope T, Teo S, Ginsberg M, et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA 2000; 284: 1677–1682.
Davis MM, King JC Jr, Moag L, Cummings G, Magder LS: Countywide school-based influenza immunization: direct and indirect impact on student absenteeism. Pediatrics 2008; 122: e260–e265.
European Centre for Disease Prevention and Control (ECDC): Infant and children seasonal immunisation against influenza on a routine basis during inter-pandemic period. ECDC: Stockholm 2007.
Nicoll A, Ciancio B, Tsolova S, Blank P, Yilmaz C: The scientific basis for offering seasonal influenza immunisation to risk groups in Europe. Euro Surveill 2008; 13(43).
Ridda I, Lindley IR, Gao Z, McIntyre P, Macintyre CR: Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people. Vaccine 2008; 26: 5633–5640.
Andrew MK, McNeil S, Merry H, Rockwood K: Rates of influenza vaccination in older adults and factors associated with vaccine use: a secondary analysis of the Canadian Study of Health and Aging. BMC Public Health 2004; 4: 36.
The Macroepidemiology of Influenza Vaccination (MIV) Study Group: The macro-epidemiology of influenza vaccination in 56 countries, 1997–2003. Vaccine 2005; 23: 5133–5143.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Blank, P.R., Schwenkglenks, M. & Szucs, T.D. Disparities in influenza vaccination coverage rates by target group in five European countries: Trends over seven consecutive seasons. Infection 37, 390–400 (2009). https://doi.org/10.1007/s15010-009-8467-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15010-009-8467-y